The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension
Open accessAbstract
Arterial hypertension is a common condition worldwide and an important predictor of several complicated diseases. Arterial hypertension can be triggered by many factors, including physiological, genetic, and lifestyle causes. Specifically, molecules of the renin-angiotensin-aldosterone system not only play important roles in the control of blood pressure, but they are also associated with the genesis of arterial hypertension, thus constituting a need for pharmacological interventions. Chronic high pressure generates mechanical damage along the vascular system, heart, and kidneys, which are the principal organs affected in this condition. In addition to mechanical stress, hypertension-induced oxidative stress, chronic inflammation, and the activation of reparative mechanisms lead to end-organ damage, mainly due to fibrosis. Clinical trials have demonstrated that renin-angiotensin-aldosterone system intervention in hypertensive patients lowers morbidity/mortality and inflammatory marker levels as compared to placebo patients, evidencing that this system controls more than blood pressure. This review emphasizes the detrimental effects that a renin-angiotensin-aldosterone system (RAAS) imbalance has on health considerations above and beyond high blood pressure, such as fibrotic end-organ damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,594
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T., Niklason, A., Luomanmäki, K., Dahlöf, B., de Faire, U., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 2,014
Molecular Mechanisms of Human Hypertension
Lifton, R. P., Gharavi, A. G., & Geller, D. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00241-0 · Cited by 1,686
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Self-citationEvidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
Hansson, L., Lindholm, L. H., Ekbom, T., Dahlöf, B., Lanke, J., Scherstén, B., Wester, P.-O., Hedner, T., & de Faire, U. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10327-1 · Cited by 1,447
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Kagami, S., Border, W. A., Miller, D. E., & Noble, N. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117251 · Cited by 1,076
Gao, X., Wu, G., Gu, X., Fu, L., & Mei, C. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000355743 · Cited by 1,035
Viberti, G., & Wheeldon, N. M. (2002) · Circulation · doi:10.1161/01.cir.0000024416.33113.0a · Cited by 802
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
Crowley, S. D., Gurley, S. B., Herrera, M. J., Ruiz, P., Griffiths, R., Kumar, A. P., Kim, H.-S., Smithies, O., Le, T. H., & Coffman, T. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605545103 · Cited by 714
Bakris, G. L., Agarwal, R., Chan, J. C., Cooper, M. E., Gansevoort, R. T., Haller, H., Remuzzi, G., Rossing, P., Schmieder, R. E., Nowack, C., et al. (2015) · JAMA · doi:10.1001/jama.2015.10081 · Cited by 708
Hypertension: Renin–Angiotensin–Aldosterone System Alterations
te Riet, L., van Esch, J. H. M., Roks, A. J. M., van den Meiracker, A. H., & Danser, A. H. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303587 · Cited by 706
The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles
Lacolley, P., Regnault, V., Nicoletti, A., Li, Z., & Michel, J.-B. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs135 · Cited by 701
The immune system and kidney disease: basic concepts and clinical implications
Kurts, C., Panzer, U., Anders, H.-J., & Rees, A. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3523 · Cited by 696
Aldosterone induces a vascular inflammatory phenotype in the rat heart
Rocha, R., Rudolph, A. E., Frierdich, G. E., Nachowiak, D. A., Kekec, B. K., Blomme, E. A. G., McMahon, E. G., & Delyani, J. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2001 · Cited by 655
Tuck, M. L., Sowers, J., Dornfeld, L., Kledzik, G., & Maxwell, M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104163041602 · Cited by 643
Scholl, U. I., Goh, G., Stölting, G., de Oliveira, R. C., Choi, M., Overton, J. D., Fonseca, A. L., Korah, R., Starker, L. F., Kunstman, J. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2695 · Cited by 627
Weight Loss and the Renin-Angiotensin-Aldosterone System
Engeli, S., Böhnke, J., Gorzelniak, K., Janke, J., Schling, P., Bader, M., Luft, F. C., & Sharma, A. M. (2005) · Hypertension · doi:10.1161/01.hyp.0000154361.47683.d3 · Cited by 624
Schmieder, R. E. (1996) · JAMA · doi:10.1001/jama.1996.03530430051039 · Cited by 604
Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J.-F., & Michel, J.-B. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.645 · Cited by 517
Control of aldosterone secretion: a model for convergence in cellular signaling pathways
SPÄT, A., & HUNYADY, L. (2004) · Physiological Reviews · doi:10.1152/physrev.00030.2003 · Cited by 494
Primary Aldosteronism and Hypertensive Disease
Mosso, L., Carvajal, C., González, A., Barraza, A., Avila, F., Montero, J., Huete, A., Gederlini, A., & Fardella, C. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000079505.25750.11 · Cited by 488
Self-citationSutherland, D. J., Ruse, J. L., & Laidlaw, J. C. (1966) · PubMed Central · Cited by 467
Fardella, C. E., Mosso, L., Gómez-Sánchez, C., Cortés, P., Soto, J., Gómez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6596 · Cited by 463
Self-citationHuman adipocytes secrete mineralocorticoid-releasing factors
Ehrhart-Bornstein, M., Lamounier-Zepter, V., Schraven, A., Langenbach, J., Willenberg, H. S., Barthel, A., Hauner, H., McCann, S. M., Scherbaum, W. A., & Bornstein, S. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336140100 · Cited by 443
Chen, M. M., Lam, A., Abraham, J. A., Schreiner, G. F., & Joly, A. H. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1215 · Cited by 442
Regulation of Blood Pressure and Salt Homeostasis by Endothelin
Kohan, D. E., Rossi, N. F., Inscho, E. W., & Pollock, D. M. (2011) · Physiological Reviews · doi:10.1152/physrev.00060.2009 · Cited by 433
Kolkhof, P., Delbeck, M., Kretschmer, A., Steinke, W., Hartmann, E., Bärfacker, L., Eitner, F., Albrecht-Küpper, B., & Schäfer, S. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000091 · Cited by 430
Ferrario, C. M., Trask, A. J., & Jessup, J. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00618.2005 · Cited by 385
The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
Pacurari, M., Kafoury, R., Tchounwou, P. B., & Ndebele, K. (2014) · International Journal of Inflammation · doi:10.1155/2014/689360 · Cited by 374
Jaffe, I. Z., & Mendelsohn, M. E. (2005) · Circulation Research · doi:10.1161/01.res.0000159937.05502.d1 · Cited by 358
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands
Nishimoto, K., Tomlins, S. A., Kuick, R., Cani, A. K., Giordano, T. J., Hovelson, D. H., Liu, C.-J., Sanjanwala, A. R., Edwards, M. A., Gomez-Sanchez, C. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505529112 · Cited by 334
Johar, S., Cave, A. C., Narayanapanicker, A., Grieve, D. J., Shah, A. M., Johar, S., Cave, A. C., Narayanapanicker, A., Grieve, D. J., & Shah, A. M. (2006) · The FASEB Journal · doi:10.1096/fj.05-4642fje · Cited by 318
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Cooper, S. A., Whaley-Connell, A., Habibi, J., Wei, Y., Lastra, G., Manrique, C., Stas, S., & Sowers, J. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00522.2007 · Cited by 317
Förstermann, U., & Li, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01196.x · Cited by 300
Fardella, C. E. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1863 · Cited by 298
Self-citationA novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism
Geller, D. S., Zhang, J., Wisgerhof, M. V., Shackleton, C., Kashgarian, M., & Lifton, R. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0594 · Cited by 296
Mennuni, S., Rubattu, S., Pierelli, G., Tocci, G., Fofi, C., & Volpe, M. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2013.55 · Cited by 292
Fibrosis — A Common Pathway to Organ Injury and Failure
(2015) · New England Journal of Medicine · doi:10.1056/nejmc1504848 · Cited by 284
Angiotensin Blockade Prevents Type 2 Diabetes by Formation of Fat Cells
Sharma, A. M., Janke, J., Gorzelniak, K., Engeli, S., & Luft, F. C. (2002) · Hypertension · doi:10.1161/01.hyp.0000036448.44066.53 · Cited by 283
Putnam, K., Shoemaker, R., Yiannikouris, F., & Cassis, L. A. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00796.2011 · Cited by 273
Toll-like Receptors in the Vascular System: Sensing the Dangers Within
Goulopoulou, S., McCarthy, C. G., & Webb, R. C. (2016) · Pharmacological Reviews · doi:10.1124/pr.114.010090 · Cited by 263
Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure
Qin, W., Rudolph, A. E., Bond, B. R., Rocha, R., Blomme, E. A. G., Goellner, J. J., Funder, J. W., & McMahon, E. G. (2003) · Circulation Research · doi:10.1161/01.res.0000080521.15238.e5 · Cited by 262
Born-Frontsberg, E., Reincke, M., Rump, L. C., Hahner, S., Diederich, S., Lorenz, R., Allolio, B., Seufert, J., Schirpenbach, C., Beuschlein, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2116 · Cited by 261
Scholl, U. I., Nelson-Williams, C., Yue, P., Grekin, R., Wyatt, R. J., Dillon, M. J., Couch, R., Hammer, L. K., Harley, F. L., Farhi, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121407109 · Cited by 259
Bauersachs, J., Jaisser, F., & Toto, R. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04488 · Cited by 257
Arciniegas, E., Sutton, A. B., Allen, T. D., & Schor, A. M. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.2.521 · Cited by 254
Nagase, M., Yoshida, S., Shibata, S., Nagase, T., Gotoda, T., Ando, K., & Fujita, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080944 · Cited by 248
Keidar, S., Kaplan, M., Pavlotzky, E., Coleman, R., Hayek, T., Hamoud, S., & Aviram, M. (2004) · Circulation · doi:10.1161/01.cir.0000127949.05756.9d · Cited by 244
Gros, R., Ding, Q., Sklar, L. A., Prossnitz, E. E., Arterburn, J. B., Chorazyczewski, J., & Feldman, R. D. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.161653 · Cited by 243
Overview of the cellular and molecular basis of kidney fibrosis
Eddy, A. A. (2014) · Kidney International Supplements · doi:10.1038/kisup.2014.2 · Cited by 242
Excess ldosterone Is Associated With Alterations of Myocardial Texture in Primary Aldosteronism
Rossi, G. P., Di Bello, V., Ganzaroli, C., Sacchetto, A., Cesari, M., Bertini, A., Giorgi, D., Scognamiglio, R., Mariani, M., & Pessina, A. C. (2002) · Hypertension · doi:10.1161/01.hyp.0000023182.68420.eb · Cited by 234
Co-expression of renin-angiotensin system genes in human adipose tissue
Engeli, S., Gorzelniak, K., Kreutz, R., Runkel, N., Distler, A., & Sharma, A. M. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917040-00014 · Cited by 233
Tsybouleva, N., Zhang, L., Chen, S., Patel, R., Lutucuta, S., Nemoto, S., DeFreitas, G., Entman, M., Carabello, B. A., Roberts, R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000121426.43044.2b · Cited by 232
Differential expression of angiotensin receptor 1A and 1B in mouse
Burson, J. M., Aguilera, G., Gross, K. W., & Sigmund, C. D. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.2.e260 · Cited by 227
Epoxy-Keto Derivative of Linoleic Acid Stimulates Aldosterone Secretion
Goodfriend, T. L., Ball, D. L., Egan, B. M., Campbell, W. B., & Nithipatikom, K. (2004) · Hypertension · doi:10.1161/01.hyp.0000113294.06704.64 · Cited by 205
Chronic Kidney Disease Progression
Eddy, A. A., & Neilson, E. G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070704 · Cited by 200
McCarthy, C. G., Wenceslau, C. F., Goulopoulou, S., Ogbi, S., Baban, B., Sullivan, J. C., Matsumoto, T., & Webb, R. C. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv137 · Cited by 193
Grossmann, C., Benesic, A., Krug, A. W., Freudinger, R., Mildenberger, S., Gassner, B., & Gekle, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0469 · Cited by 178
Aldosterone and arterial hypertension
Tomaschitz, A., Pilz, S., Ritz, E., Obermayer-Pietsch, B. M., & Pieber, T. R. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.263 · Cited by 176
Mulatero, P., Tizzani, D., Viola, A., Bertello, C., Monticone, S., Mengozzi, G., Schiavone, D., Williams, T. A., Einaudi, S., Grotta, A. L., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.175083 · Cited by 172
Local Angiotensin II and Transforming Growth Factor-β1 in Renal Fibrosis of Rats
Sun, Y., Zhang, J., Zhang, J. Q., & Ramires, F. J. A. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1078 · Cited by 166
Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells
Hiroki, J., Shimokawa, H., Higashi, M., Morikawa, K., Kandabashi, T., Kawamura, N., Kubota, T., Ichiki, T., Amano, M., Kaibuchi, K., et al. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.008 · Cited by 160
Editore, S. (2015) · Cited by 159
Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload
HA, T., LI, Y., HUA, F., MA, J., Gao, X. J., Kelley, J., Zhao, A. T., Haddad, G. E., WILLIAMS, D., & WILLIAMBROWDER, I. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.05.025 · Cited by 152
Skurk, T., Lee, Y., & Hauner, H. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1336 · Cited by 150
CLINICAL AND PATHOLOGICAL DIVERSITY OF PRIMARY ALDOSTERONISM, INCLUDING A NEW FAMILIAL VARIETY
Gordon, R. D., Stowasser, M., Tunny, T. J., Klemm, S. A., Finn, W. L., & Krek, A. L. (1991) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1991.tb01446.x · Cited by 146
Ogishima, T., Shibata, H., Shimada, H., Mitani, F., Suzuki, H., Saruta, T., & Ishimura, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99077-0 · Cited by 141
Hernanz, R., Martínez‐Revelles, S., Palacios, R., Martín, Á., Cachofeiro, V., Aguado, A., García-Redondo, L., Barrús, M. T., de Batista, P. R., Briones, A. M., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13117 · Cited by 141
Charmandari, E., Sertedaki, A., Kino, T., Merakou, C., Hoffman, D. A., Hatch, M. M., Hurt, D. E., Lin, L., Xekouki, P., Stratakis, C. A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1334 · Cited by 138
Aldosterone Induces Superoxide Generation via Rac1 Activation in Endothelial Cells
Iwashima, F., Yoshimoto, T., Minami, I., Sakurada, M., Hirono, Y., & Hirata, Y. (2007) · Endocrinology · doi:10.1210/en.2007-0864 · Cited by 134
Rossignol, P., Ménard, J., Fay, R., Gustafsson, F., Pitt, B., & Zannad, F. M. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.049 · Cited by 128
Hayashi, H., Kobara, M., Masaki, A. B. E., Tanaka, N., Gouda, E., Toba, H., Yamada, H., Tatsumi, T., Nakata, T., & Matsubara, H. (2008) · Hypertension Research · doi:10.1291/hypres.31.363 · Cited by 123
Calò, L. A., Zaghetto, F., Pagnin, E., Davis, P. A., de Mozzi, P., Sartorato, P., Martire, G., Fiore, C., & Armanini, D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031545 · Cited by 122
Náray‐Fejes‐Tóth, A., & Fejes‐Tóth, G. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00964.x · Cited by 113
Aldosterone Blockade: An Emerging Strategy for Abrogating Progressive Renal Disease
Epstein, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.038 · Cited by 112
Hirono, Y., Yoshimoto, T., Suzuki, N., Sugiyama, T., Sakurada, M., Takai, S., Kobayashi, N., Shichiri, M., & Hirata, Y. (2007) · Endocrinology · doi:10.1210/en.2006-1157 · Cited by 110
Distribution of angiotensin II receptors in rat and human adipocytes.
Crandall, D. L., Herzlinger, H. E., Saunders, B., Armellino, D. C., & Kral, J. G. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40079-3 · Cited by 100
Pitt, B., Anker, S. D., Böhm, M., Gheorghiade, M., Køber, L., Krum, H., Maggioni, A. P., Ponikowski, P. P., Voors, A. A., Zannad, F. M., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.218 · Cited by 98
Hypertension augments cardiac Toll-like receptor 4 expression and activity
Eißler, R., Schmaderer, C., Rusai, K., Kühne, L., Sollinger, D., Lahmer, T., Witzke, O., Lutz, J., Heemann, U. W., & Baumann, M. (2011) · Hypertension Research · doi:10.1038/hr.2010.270 · Cited by 95
Functional Effects of Rho-Kinase–Dependent Phosphorylation of Specific Sites on Cardiac Troponin
Vahebi, S., Kobayashi, T., Warren, C. M., de Tombe, P. P., & Solaro, R. J. (2005) · Circulation Research · doi:10.1161/01.res.0000162457.56568.7d · Cited by 94
Buglioni, A., Cannone, V., Cataliotti, A., Sangaralingham, S. J., Heublein, D. M., Scott, C. G., Bailey, K. R., Rodeheffer, R. J., Dessì-Fulgheri, P., Sarzani, R., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03936 · Cited by 94
Taira, M., Toba, H., Murakami, M., Iga, I., Serizawa, R., Murata, S., Kobara, M., & Nakata, T. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.019 · Cited by 93
Lemarié, C. A., Simeone, S., Nikonova, A. S., Ebrahimian, T., Deschênes, M.-E., Coffman, T. M., Paradis, P., & Schiffrin, E. L. (2009) · Circulation Research · doi:10.1161/circresaha.109.196576 · Cited by 92
Stehr, C. B., Mellado, R., Ocaranza, M. P., Carvajal, C. A., Mosso, L., Becerra, E., Solis, M., García, L., Lavandero, S., Jalil, J., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833d0177 · Cited by 88
Self-citationMartins, L. C., Figueiredo, V. N., Quinaglia, T., Boer‐Martins, L., Yugar‐Toledo, J. C., Vilela-Martin, J. F., Demacq, C., Pimenta, E., Calhoun, D. A., & Moreno, H. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.95 · Cited by 88
Ito, T., Yoshimura, M., Nakamura, S., Nakayama, M., Shimasaki, Y., Harada, E., Mizuno, Y., Yamamuro, M., Harada, M., Saito, Y., et al. (2003) · Circulation · doi:10.1161/01.cir.0000057794.29667.08 · Cited by 88
Nielsen, S. E., Persson, F., Frandsen, E., Sugaya, T., Hess, G., Zdunek, D., Schjoedt, K. J., Parving, H. ‐., & Rossing, P. R. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03585.x · Cited by 86
Metabolic risk factors and renal disease
Sowers, J. R. (2007) · Kidney International · doi:10.1038/sj.ki.5002006 · Cited by 85
Prorenin and the (pro)renin receptor--an update
Danser, A. H. J., Batenburg, W. W., & van Esch, J. H. M. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl846 · Cited by 81
A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone
López‐Andrés, N., Martín‐Fernández, B., Rossignol, P., Zannad, F. M., Lahera, V., Fortuño, M. A., Cachofeiro, V., & Dı́ez, J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00283.2011 · Cited by 78
Kim, S., Whelan, J., Moustaïd‐Moussa, N., Claycombe, K., & Reath, D. B. (2002) · Journal of Nutrition · doi:10.1093/jn/132.6.1135 · Cited by 76
Novel Genes Regulated by the Insulin Sensitizer Rosiglitazone During Adipocyte Differentiation
Albrektsen, T., Frederiksen, K. S., Holmes, W. E., Boel, E., Taylor, K. J., & Fleckner, J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1042 · Cited by 76
The Role of Aldosteronism in Causing Obesity-Related Cardiovascular Risk
Calhoun, D. A., & Sharma, K. (2010) · Cardiology Clinics · doi:10.1016/j.ccl.2010.04.001 · Cited by 74
Dall’Asta, C., Vedani, P., Manunta, P., Pizzocri, P., Marchi, M., Paganelli, M., Folli, F. B., & Pontiroli, A. E. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.06.001 · Cited by 73
Derfoul, A., Robertson, N. M., Lingrel, J. B., Hall, D. J., & Litwack, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.20702 · Cited by 72
Habibi, J., DeMarco, V. G., Ma, L., Pulakat, L., Rainey, W. E., Whaley‐Connell, A. T., & Sowers, J. R. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01000.2010 · Cited by 69
Zhang, Y., Peng, W., Ao, X., Dai, H., Yuan, L., Huang, X., & Zhou, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142456 · Cited by 65
Shimokawa, H., & Satoh, K. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305353 · Cited by 57
Endothelin-1 expression in vascular adventitial fibroblasts
An, S. J., Boyd, R., Wang, Y., Qiu, X., & Wang, H. D. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00326.2005 · Cited by 55
Aldosterone Inhibits Inducible Nitric Oxide Synthase in Neonatal Rat Cardiomyocytes
Chun, T.-Y., Bloem, L. J., & Pratt, J. H. (2003) · Endocrinology · doi:10.1210/en.2002-220956 · Cited by 54
Leung, J. C. K., Chan, L. Y. Y., Tsang, A. W. L., Liu, E., Lam, M. F., Tang, S. C. W., & Lai, K. N. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh323 · Cited by 48
Martínez‐Aguayo, A., Marlene Aglony, I., Campino, C., García, H., Bancalari, R. E., Bolte, L., Avalos, C., Loureiro, C., Carvajal, C. A., Ávila, A., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.155135 · Cited by 48
Self-citationLynch, I. J., Welch, A., Kohan, D. E., Cain, B. D., & Wingo, C. S. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00613.2012 · Cited by 46
Fardella, C., Pinto, M. P., Mosso, L. M., Gómez-Sánchez, C. E., Jalil, J., & Montero, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7920 · Cited by 46
Self-citationAldosterone increases VEGF-A production in human neutrophils through PI3K, ERK1/2 and p38 pathways
Walczak, C., Gaignier, F., Gilet, A., Zou, F., Thornton, S. N., & Ropars, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.07.010 · Cited by 44
Macrophage Migration Inhibitory Factor in Clinical Kidney Disease
Bruchfeld, A. N., Wendt, M., & Miller, E. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00008 · Cited by 43
Aldosterone induces electrical remodeling independent of hypertension
Dartsch, T., Fischer, R., Gapelyuk, A., Weiergräber, M., Ladage, D., Schneider, T., Schirdewan, A., Reuter, H., Mueller-Ehmsen, J., & Zobel, C. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.06.100 · Cited by 38
The Development of Hypertension and Hyperaldosteronism in a Rodent Model of Life-Long Obesity
Northcott, C. A., Fink, G. D., Garver, H. S., Haywood, J. R., Laimon-Thomson, E. L., McClain, J. L., Pires, P. W., Rainey, W. E., Rigsby, C. S., & Dorrance, A. M. (2012) · Endocrinology · doi:10.1210/en.2011-1176 · Cited by 34
Local Control of Aldosterone Production and Primary Aldosteronism
Lalli, E., Barhanin, J., Zennaro, M., & Warth, R. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.01.003 · Cited by 34
Nielsen, S. E., Schjoedt, K. J., Rossing, K., Persson, F., Schalkwijk, C. G., Stehouwer, C. D. A., Parving, H., & Rossing, P. R. (2012) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320312460290 · Cited by 28
Carvajal, C. A., Campino, C., Martínez‐Aguayo, A., Tichauer, J. E., Bancalari, R. E., Valdivia, C. P., Trejo, P., Marlene Aglony, I., Baudrand, R. F., Lagos, C. F., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.180513 · Cited by 28
Self-citationMartín‐Fernández, B., Heras, N. D. L., Miana, M., Ballesteros, S., Delgado, C., Song, S. S., Hintze, T. H., Cachofeiro, V., & Lahera, V. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31820088ca · Cited by 23
Renal injury in extreme obesity: the important role of aldosterone
Bomback, A. S., & Klemmer, P. J. (2008) · Kidney International · doi:10.1038/ki.2008.429 · Cited by 17
Loureiro, C., Campino, C., Martínez‐Aguayo, A., Godoy, I. E., Marlene Aglony, I., Bancalari, R. E., García, H., Carvajal, C. A., & Fardella, C. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04503.x · Cited by 15
Self-citationFardella, C., Mosso, L. M., & Carvajal, C. A. (2008) · Revista médica de Chile · doi:10.4067/s0034-98872008000700014 · Cited by 7
Self-citation
Cited by
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Microalgae for High-Value Products Towards Human Health and Nutrition
Barkia, I., Saari, N., & Manning, S. R. (2019) · Marine Drugs · doi:10.3390/md17050304 · Cited by 719
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety
Shaito, A., Thuan, D. T. B., Phu, H. T., Nguyen, T. H. D., Hasan, H., Halabi, S., Abdelhady, S., Nasrallah, G. K., Eid, A. H., & Pintus, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00422 · Cited by 437
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Zamorano Cuervo, N., & Grandvaux, N. (2020) · eLife · doi:10.7554/elife.61390 · Cited by 313
Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress
Xiang, D., Liu, Y., Zhou, S., Zhou, E., & Wang, Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5523516 · Cited by 286
Metadata
- Authors
- Muñoz-Durango, N., Fuentes, C., Castillo, A., González-Gómez, L., Vecchiola, A., Fardella, C., & Kalergis, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2016-06-23
- Volume
- 17
- Issue
- 7
- Pages
- 797
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2472187086
- Cited by
- 282
- References
- 121
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.